Jun Kang

ORCID: 0000-0002-7967-0917
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • HER2/EGFR in Cancer Research
  • Cancer Immunotherapy and Biomarkers
  • CRISPR and Genetic Engineering
  • Radiomics and Machine Learning in Medical Imaging
  • Breast Cancer Treatment Studies
  • Genetic factors in colorectal cancer
  • PARP inhibition in cancer therapy
  • Monoclonal and Polyclonal Antibodies Research
  • Ovarian cancer diagnosis and treatment
  • Lung Cancer Treatments and Mutations
  • Endometrial and Cervical Cancer Treatments
  • Cancer Cells and Metastasis
  • Molecular Biology Techniques and Applications
  • DNA Repair Mechanisms
  • Cancer-related Molecular Pathways
  • Advanced Biosensing Techniques and Applications
  • Lung Cancer Diagnosis and Treatment
  • Estrogen and related hormone effects
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Metastasis and carcinoma case studies
  • Lung Cancer Research Studies
  • Breast Lesions and Carcinomas
  • Sarcoma Diagnosis and Treatment

Catholic University of Korea
2015-2025

Seoul St. Mary's Hospital
2019-2025

Beijing University of Posts and Telecommunications
2024

Seoul National University
2019-2022

Incheon St. Mary's Hospital
2014-2018

Inje University Haeundae Paik Hospital
2012-2013

Military Manpower Administration
2009-2011

Uijeongbu St. Mary's Hospital
2009

Growing evidence suggests that the efficacy of immunotherapy in non-small cell lung cancers (NSCLCs) is associated with immune microenvironment within tumor. We aimed to explore radiologic phenotyping using a radiomics approach assess NSCLC. Two independent NSCLC cohorts (training and test sets) were included. Single-sample gene set enrichment analysis was used determine tumor microenvironment, where type 1 helper T (Th1) cells, 2 (Th2) cytotoxic cells targets for prediction computed...

10.1371/journal.pone.0231227 article EN cc-by PLoS ONE 2020-04-06

Abstract Targeted next-generation sequencing (NGS) technology detects specific mutations that can provide treatment opportunities for colorectal cancer (CRC) patients. We included 145 CRC patients who underwent surgery. analyzed the mutation frequencies of common actionable genes and their association with clinicopathological characteristics oncologic outcomes using targeted NGS. Approximately 97.9% (142) showed somatic mutations. Frequent were observed in TP53 (70%), APC (60%), KRAS (49%)....

10.1038/s41598-021-87486-3 article EN cc-by Scientific Reports 2021-04-14

Background Spread through air spaces (STAS) has recently been demonstrated to exhibit a negative impact on lung adenocarcinoma prognosis. However, most of these studies investigated STAS in nonmucinous adenocarcinoma. Here, we the incidence invasive mucinous (IMA) and evaluated whether tumor was risk factor disease recurrence IMA. We also examined clinicoradiologic factors patients with IMA harboring STAS. Methods reviewed pathologic specimens imaging characteristics primary tumors from 132...

10.1111/1759-7714.13632 article EN cc-by-nc-nd Thoracic Cancer 2020-09-25

Aims Immunohistochemical (IHC) staining of p53 is a potential marker for TP53 mutations in various cancers. However, criteria predicting triple‐negative breast cancer (TNBC) using IHC are not yet established. We aim to correlate expression patterns with mutation status TNBC. Methods and Results A total 113 TNBC cases were analysed pattern somatic whole‐exome sequencing. Functional properties determined the National Cancer Institute (NCI) database. P53 categorized as nuclear overexpression (...

10.1111/his.15453 article EN cc-by Histopathology 2025-03-31

Abstract In our previous study, we developed a triple-negative breast cancer (TNBC) subtype classification that correlated with the TNBC molecular subclassification. this aimed to evaluate predictor variables of on whole slide and validate model’s performance by using an external test set. We explored characteristics investigated genomic alterations, including scar signature scores. First, was classified into luminal androgen receptor (LAR) non-luminal (non-LAR) subtypes based AR Allred...

10.1038/s41598-024-61640-z article EN cc-by Scientific Reports 2024-05-17

Insulin-like growth factor 1 receptor (IGF-1R) is commonly expressed in primary breast cancers. Understanding the role of IGF-1R signaling different subtypes cancer important because each subtype has a outcome and requires treatment modalities. However, precise biological significance expression cells still unclear. In this study, we examined molecular cancer. The effects on survival rates outcomes were also examined.

10.4048/jbc.2014.17.2.113 article EN cc-by-nc Journal of Breast Cancer 2014-01-01

Trichophyton usually causes a superficial skin infection, affecting the outermost layer of epidermis, stratum corneum. In immunocompromised patients, deeper invasion into dermis and even severe systemic infection with distant organ involvement can occur. Most cases dermal dermatophytosis described in literature so far involved pre-existing dermatophytosis. We report 68-year-old woman presented to our clinic 3-month history palpable nodules on right ankle without Magnetic resonance imaging...

10.1186/s12879-016-1631-y article EN cc-by BMC Infectious Diseases 2016-06-17

We investigated the patterns and timing of recurrence death as well prognostic factors based on clinicopathological radiological in patients who underwent surgical treatment for invasive mucinous adenocarcinoma (IMA).We reviewed findings including spread through air spaces (STAS) CT IMA such morphology, solidity, margin, well-defined heterogeneous ground-glass opacity, angiogram, bronchogram signs from 121 consecutive resection. Prognostic disease-free survival (DFS) overall (OS) were...

10.1186/s13244-022-01208-5 article EN cc-by Insights into Imaging 2022-04-05

Background One of the two copies X chromosome is randomly inactivated in females as a means dosage compensation. Loss inactivation (XCI) observed breast and ovarian cancers, frequent basal-like subtype BRCA1 mutation-associated cancers. We investigated clinical implications loss XCI cancer association between dysfunction. Materials Methods used open source data generated by The Cancer Genome Atlas (TCGA) Data Analysis Centers. Ward's hierarchical clustering method was to classify methylation...

10.1371/journal.pone.0118927 article EN cc-by PLoS ONE 2015-03-05

Amelogenesis imperfecta (AI) is a collection of genetic disorders affecting the quality and/or quantity tooth enamel. More than 20 genes are, so far, known to be responsible for this condition. In study, we recruited 3 Turkish families with hypomaturation AI. Whole-exome sequence analyses identified disease-causing mutations in each proband, and these cosegregated AI phenotype all members family. The AI-causing family 1 were novel

10.1177/0022034520901708 article EN Journal of Dental Research 2020-01-30

Studies correlating specific genetic mutations and treatment response are ongoing to establish an effective strategy for gastric cancer (GC). To facilitate this research, a cost- time-effective method analyze the mutational status is necessary. Deep learning (DL) has been successfully applied hematoxylin eosin (H E)-stained tissue slide images.

10.3748/wjg.v27.i44.7687 article EN cc-by-nc World Journal of Gastroenterology 2021-11-25

Objective Poly(ADP-ribose) polymerase (PARP) inhibitors are used for targeted therapy ovarian cancer with homologous recombination deficiency (HRD). In this study, we aimed to develop a prediction model predict the genomic integrity (GI) index of SOPHiA DDM HRD Solution from Oncomine Comprehensive Assay (OCA) Plus. We also tried find cut-off value instability metric (GIM) OCA Plus that correlates GI Solution. Methods included 87 cases high-grade serous carcinoma five tertiary referral...

10.1371/journal.pone.0298128 article EN cc-by PLoS ONE 2024-03-25

Amplification of the human epidermal growth factor receptor 2 (HER2) gene occurs in 18% to 20% breast cancers, and it is recognized as a prognostic predictive marker. We investigated HER2 status Korean cancer by immunohistochemistry (IHC) silver-enhanced situ hybridization (SISH), first step toward building nationwide quality assurance program for testing.A total 1,198 carcinoma samples were collected from six institutions IHC SISH performed using tissue microarrays central laboratories. The...

10.4048/jbc.2012.15.4.381 article EN cc-by-nc Journal of Breast Cancer 2012-01-01

Accurate molecular classification of breast core needle biopsy (CNB) tissue is important for determining neoadjuvant systemic therapies invasive cancer. The researchers aimed to evaluate the concordance rate (CR) subtypes between CNBs and surgical specimens.This study was conducted with cancer patients who underwent surgery after CNB at Seoul St. Mary's Hospital December 2014 2017. Estrogen receptor (ER), progesterone (PR), human epidermal growth factor 2 (HER2), Ki67 were analyzed using...

10.4132/jptm.2019.10.14 article EN cc-by-nc Journal of Pathology and Translational Medicine 2019-11-13

We investigated the clinical implications of biallelic loss PTEN in clear cell renal carcinoma and whether would induce p53 dependent cellular senescence.Data were obtained using CGDS-R package from TCGA data set kirc_tcga_pub. allelic status was classified into 3 groups, including (homozygous deletion or combined heterozygous mutation), monoallelic (heterozygous mutation) absent loss. Univariate multivariate overall survival analysis performed. TP53 mean expression genes related to...

10.1016/j.juro.2014.03.097 article EN The Journal of Urology 2014-04-01

Detecting high-risk (HR) HPV is important for clinical management of women with persistent HPV-positive and Pap-negative results. The Cobas 4800 test the first FDA-approved DNA that can be used alone as a first-line screening tool. 9G chip PCR-based microarray assay. We evaluated patients consecutive HPV-positivity on without cytologic abnormalities. then compared performances tests detecting HR each other confirmed genotyping using direct sequencing. All 214 liquid-based cytology specimens...

10.1371/journal.pone.0140336 article EN cc-by PLoS ONE 2015-10-15

Triple-negative breast cancer (TNBC) is an aggressive type of cancer. Currently, no effective treatment options for this condition exist. Nuclear factor erythroid 2-related 2 (NRF2), encoded by nuclear erythroid-derived 2-like (NFE2L2) gene and its endogenous inhibitor, Kelch-like ECH-associated protein 1 (KEAP1), both participate in cellular defense mechanisms against oxidative stress contribute to chemoresistance tumor progression numerous types cancers. This study aimed evaluate the...

10.4048/jbc.2023.26.e42 article EN cc-by-nc Journal of Breast Cancer 2023-01-01
Coming Soon ...